Bex, A, Van Thienen, J V, Schrier, M, Graafland, N, Kuusk, T, Hendricksen, K, Lagerveld, B, Zondervan, P, van Moorselaar, J R A, Blank, C, Wilgenbos, S & Haanen, J 2019, ' A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX) ', Future Oncology, vol. 15, no. 19, pp. 2203-2209 . https://doi.org/10.2217/fon-2019-0111 Future Oncology, 15(19), 2203-2209. Future Medicine Ltd. Future oncology (London, England), 15(19), 2203-2209. Future Medicine Ltd.
Clinical cancer research, 25(22), 6598-6605. American Association for Cancer Research Inc. Clinical Cancer Research, 25(22), 6598. American Association for Cancer Research Inc.